D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWCH
3026
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.72M | ﹤0.01% |
+67,682
| New | +$1.59M |
|
3027
American Vanguard Corp
AVD
$68.7M
| $1.71M | ﹤0.01% |
113,626
+92,761
| +445% | +$1.47M |
|
3028
Steris
STE
$22.9B
| $1.71M | ﹤0.01% |
8,362
-119,929
| -93% | -$25.7M |
|
|
GMDA
3029
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $1.71M | ﹤0.01% |
435,368
+295,928
| +212% | +$1.48M |
|
3030
Banco Macro
BMA
$5.81B
| $1.71M | ﹤0.01% |
100,337
-25,990
| -21% | -$411K |
|
3031
Tandem Diabetes Care
TNDM
$1.27B
| $1.7M | ﹤0.01% |
14,265
-929
| -6% | -$102K |
|
3032
Butterfly Network
BFLY
$1.86B
| $1.7M | ﹤0.01% |
+163,026
| New | +$1.88M |
|
3033
Prologis
PLD
$136B
| $1.7M | ﹤0.01% |
13,568
-104,859
| -89% | -$13.6M |
|
3034
CALL
Sprout Social
SPT
$530M
| $1.7M | ﹤0.01% |
13,900
+3,900
| +39% | +$424K |
|
|
HCII
3035
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
| $1.7M | ﹤0.01% |
173,869
+30,995
| +22% | +$302K |
|
3036
AGCO
AGCO
$8.41B
| $1.69M | ﹤0.01% |
13,803
+4,146
| +43% | +$542K |
|
3037
Covenant Logistics
CVLG
$1.04B
| $1.68M | ﹤0.01% |
121,694
-13,078
| -10% | -$146K |
|
|
MSAC
3038
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $1.68M | ﹤0.01% |
+172,065
| New | +$1.66M |
|
|
TUP
3039
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $1.68M | ﹤0.01% |
79,300
+60,000
| +311% | +$1.34M |
|
|
MZTI
3040
The Marzetti Company
MZTI
$3.05B
| $1.67M | ﹤0.01% |
9,885
+8,605
| +672% | +$1.59M |
|
|
MAGN
3041
Magnera Corp
MAGN
$493M
| $1.67M | ﹤0.01% |
9,089
-6,481
| -42% | -$1.26M |
|
|
HUGS
3042
DELISTED
USHG Acquisition Corp.
HUGS
| $1.66M | ﹤0.01% |
+171,378
| New | +$1.66M |
|
3043
CALL
Harley-Davidson
HOG
$2.61B
| $1.66M | ﹤0.01% |
45,400
-5,000
| -10% | -$202K |
|
|
BGFV
3044
DELISTED
Big 5 Sporting Goods
BGFV
| $1.66M | ﹤0.01% |
72,087
-37,430
| -34% | -$918K |
|
3045
Local Bounti
LOCL
$23M
| $1.66M | ﹤0.01% |
12,816
| – | – |
|
3046
MacroGenics
MGNX
$233M
| $1.65M | ﹤0.01% |
78,712
-48,932
| -38% | -$1.18M |
|
3047
Nuvation Bio
NUVB
$2.29B
| $1.65M | ﹤0.01% |
165,491
-3,424
| -2% | -$31K |
|
|
PAQC
3048
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
| $1.64M | ﹤0.01% |
+168,610
| New | +$1.63M |
|
3049
Bunge Global
BG
$20.9B
| $1.64M | ﹤0.01% |
20,162
+8,945
| +80% | +$690K |
|
|
SEMR
3050
DELISTED
Semrush
SEMR
| $1.64M | ﹤0.01% |
71,127
-2,784
| -4% | -$64.2K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.